Smith & Nephew Logs Higher Q1 Revenue; FY24 Guidance Affirmed
Smith & Nephew (SN.L) on Wednesday reported a year-over-year increase to its revenue in the first quarter. The medical technology group's revenue for the three months ended March 30 was nearly $1.39 b
MT NewswiresMay 1 02:37 ET
Smith & Nephew Confident in Outlook in All Three of Business Units
Smith & Nephew Confident in Outlook in All Three of Business Units
Dow JonesMay 1 02:11 ET
Smith & Nephew Sees 2024 Underlying Rev Growth of 5.0%-6.0%
Smith & Nephew Sees 2024 Underlying Rev Growth of 5.0%-6.0%
Dow JonesMay 1 02:10 ET
Earnings Flash (SN.L) SMITH & NEPHEW Posts Q1 Revenue $1.39B
02:08 AM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (SN.L) SMITH & NEPHEW Posts Q1 Revenue $1.39B
MT NewswiresMay 1 02:08 ET
Smith & Nephew 1Q Orthopaedics Rev Up 4.4% on Underlying Basis
Smith & Nephew 1Q Orthopaedics Rev Up 4.4% on Underlying Basis
Dow JonesMay 1 02:08 ET
Smith & Nephew Saw Continued Weakness in US Hip and Knee Implants
Smith & Nephew Saw Continued Weakness in US Hip and Knee Implants
Dow JonesMay 1 02:08 ET
Smith & Nephew 1Q Rev $1.39B
Smith & Nephew 1Q Rev $1.39B
Dow JonesMay 1 02:03 ET
Smith & Nephew Plc Backs 2024 View
Smith & Nephew Plc Backs 2024 View
Dow JonesMay 1 02:01 ET
Europe Scar Management Market Analysis Report 2024: A $350+ Million Market by 2030 With Advancis Medical, Bayer, B. Braun, Molnlycke Health Care, Smith & Nephew, and Stratpharma Dominating
Yahoo FinanceApr 29 10:07 ET
With 83% Ownership of the Shares, Smith & Nephew Plc (LON:SN.) Is Heavily Dominated by Institutional Owners
Yahoo FinanceApr 22 03:15 ET
Smith+Nephew Announces New Evidence Supporting ALLEVYN LIFE Foam Dressing's Role in Pressure Injury Prevention
Smith+Nephew (NYSE:SNN, LSE:SN)), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the
GlobeNewswireApr 18 07:00 ET
Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.
Yahoo FinanceApr 18 04:55 ET
Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal
Proxy advisers cautioned Smith & Nephew (SN.L) shareholders regarding a new pay policy as part of a plan to reduce turnover of the company's executives. Institutional Shareholder Services urged shareh
MT NewswiresApr 11 08:54 ET
JPMorgan's Top European Picks
JPMorgan analysts published their list of top European stocks.
Seeking AlphaApr 9 12:55 ET
Smith+Nephew Signs Exclusive Distribution Agreement to Provide Unique NAVBIT SPRINT Solution in Australia
Yahoo FinanceApr 8 18:00 ET
Here's Why You Should Invest in Smith & Nephew Plc (SNN)
Yahoo FinanceApr 8 11:27 ET
Smith & Nephew Says UK NICE Reaffirms Guidance on Pico Wound Dressing
Smith & Nephew (SNN) said Thursday that the UK National Institute for Health and Care Excellence has reaffirmed its guidance that the company's negative pressure wound dressing be considered an option
MT NewswiresApr 4 13:44 ET
Smith+Nephew's PICO Single Use Negative Pressure Wound Therapy System Provides Better Clinical Outcomes Versus Standard of Care According to UK National Institute for Health and Care Excellence (NICE)
Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) for its PICO
GlobeNewswireApr 4 11:13 ET
Investors Five-year Losses Continue as Smith & Nephew (LON:SN.) Dips a Further 5.6% This Week, Earnings Continue to Decline
Yahoo FinanceApr 3 08:30 ET
Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN), Ocuphire Pharma (OCUP) and Vertex Pharmaceuticals (VRTX)
TipRanksApr 2 07:20 ET
No Data
No Data